𝗛𝗼𝘄 𝘁𝗼 𝗦𝗣𝗢𝗧 𝘁𝗵𝗲 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲? The ELISpot Resource Group (ERG) organizes a free ELISpot/FluoroSpot workshop to inform you about the ELISpot technique, new developments, and control. The next ELISpot workshop will be hosted by BioNTech SE in Munich on April 2nd. The ERG consists of ELISpot enthusiasts from ZellNet Consulting, Mabtech, Merck Group, and yours truly, JPT Peptide Technologies. We are excited to meet you. So, sign up & let’s connect! Please find the signup link in the comments 💬 👇 #myjpt #elispot #webinar Sylvia Janetzki
About us
We are the Peptide Experts! JPT has a large peptide synthesis capacity, providing over 1 million peptides per year. We offer all possible peptide modifications such as macrocyclic peptides, phosphorylated peptides, labeled and tagged peptides, radioligands, isotope labeling and more. Made in Germany Global Support More than 20 Years of Expertise Ethical, Environmental & Health Standards Portfolio: Custom Peptides Our patented technologies in peptide libraries, pools, microarrays, and micro-scale synthesis set us apart as a leader in the field. From micro to large-scale synthesis, our state-of-the-art labs in Germany deliver peptides tailored to your needs. Modified Peptides We produce modified peptides such as long and stapled peptides, dyes, labeled and biotinylated peptides, PTMs, unique building blocks, conjugations, macrocyclic peptides and more. PepMix Peptide Pools Peptide pools for antigen-specific T-cell stimulation in immune monitoring, assay control, cell therapy development, T-cell expansion etc. In addition to custom PepMix peptide pools we have more than 500 PepMixes in stock, for example: Control Pools: CEFX, CEF, Actin, CMV pp65 … Viral Proteins of EBV, SARS-CoV-2, CMV, VZV, HPV … TAA: Prame, NY-ESO-1, MART-1, MAGE A … Clinical Peptides & Pools Our resulting Clinical Grade Peptides have been approved for a variety of clinical applications including immunotherapy and vaccine development, immune monitoring, and clinical proteomics. Please visit our website for more information! JPT Peptide Technologies GmbH Management: Aurélien Claeyssen, Jens Holstein, Dr. Sierk Poetting Volmerstr. 5 D- 12489 Berlin T: +49 30 6392 5500 peptide@jpt.com https://www.jpt.com/ Registration Court: Berlin / Amtsgericht Charlottenburg, HRB 92692 VAT identification number: DE 814044483 Imprint: https://www.jpt.com/support-contact/corporate/imprint/ Privacy Policy: https://www.jpt.com/support-contact/corporate/privacy-policy/
- Website
-
https://www.jpt.com/
External link for JPT Peptide Technologies
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Berlin
- Type
- Privately Held
- Founded
- 2004
- Specialties
- Peptide Synthesis, Peptide Microarrays, Peptide Libraries, Peptide Pools, Proteotypic Peptides, Stable Isotope labeled peptides, Immunotherapy, Clinical Peptides, Peptide Analyses, Custom Peptides, Macrocyclic Peptides, Made in Germany, DOTA peptides, Radioligands, Cell penetrating peptides, T cell controls, and ELISpot Service
Locations
-
Primary
Get directions
JPT Peptide Technologies GmbH
Volmerstraße 5
Berlin, 12489, DE
Employees at JPT Peptide Technologies
Updates
-
𝗔𝗻𝗼𝘁𝗵𝗲𝗿 𝗼𝗻𝗲? 𝗢𝗻𝗲 𝗺𝗼𝗿𝗲 𝗳𝗿𝗲𝗲 𝗘𝗟𝗜𝗦𝗽𝗼𝘁 𝗪𝗲𝗯𝗶𝗻𝗮𝗿, 𝘁𝗵𝗶𝘀 𝘁𝗶𝗺𝗲 𝗶𝗻 𝗢𝘅𝗳𝗼𝗿𝗱! The ELISpot Resource Group (ERG) regularly organizes free ELISpot/FluoroSpot workshops worldwide to inform about the ELISpot technique, new developments, and control. The ERG consists of ELISpot enthusiasts from ZellNet Consulting, Mabtech, Merck Group, and yours truly, JPT Peptide Technologies. This time, the next ELISpot workshop will be hosted by Jenner Institute in Oxford on April 3rd. We are excited to meet you. So, sign up & connect with Michael Drosch, or Sylvia Janetzki! Please find the signup link in the comments 💬 👇 #myjpt #elispot #webinar
-
-
JPT Peptide Technologies reposted this
Providing tailored peptide solution for your project - JPT Peptide Technologies is part of BioNTech SE
🚨 Exciting News! 🚨 Michael Drosch and I will be at the NextGen Biomed by Oxford Global in #London starting this Wednesday (12/03), representing JPT Peptide Technologies at Booth #13! If you're attending, come by to chat about the latest in #peptide technologies, cutting-edge research solutions, and how JPT can support your work. Looking forward to connecting with fellow scientists, researchers, and industry leaders! 📍 Booth #13 📅 From the Wednesday 12th to Friday 14th of March 2025 Let’s meet and discuss innovation in the peptide world! Feel free to drop by or message me to set up a time to connect. See you there! #BiomedNextGen #PeptideTechnology #JPTPeptides #Networking #Innovation #myjpt
-
📢 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗘𝗱𝗴𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝗹𝗲𝗿𝘁! A roundup of new research in 𝗜𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝘆, 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗚𝗲𝗻𝗲𝘁𝗶𝗰𝘀/𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆, and 𝗡𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲, all starring JPT peptides! Sometimes, February seems to go by faster than other months… However, this short month still produced many interesting publications covering a variety of topics. Check out this month’s highlights and see how our peptides are playing a key role in advancing biomedical research!👇 🔹 Using Small Custom matrix peptide pools for Epitope Validation following adaptive mutation prediction models for Measles: 𝗜𝗺𝗽𝗮𝗰𝘁 𝗼𝗳 𝗴𝗲𝗻𝗼𝘁𝘆𝗽𝗶𝗰 𝘃𝗮𝗿𝗶𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗼𝗳 𝗺𝗲𝗮𝘀𝗹𝗲𝘀 𝘃𝗶𝗿𝘂𝘀 𝗧-𝗰𝗲𝗹𝗹 𝗲𝗽𝗶𝘁𝗼𝗽𝗲𝘀 𝗼𝗻 𝘃𝗮𝗰𝗰𝗶𝗻𝗲-𝗶𝗻𝗱𝘂𝗰𝗲𝗱 𝗧-𝗰𝗲𝗹𝗹 𝗶𝗺𝗺𝘂𝗻𝗶𝘁𝘆 ✍ Maarten Emmelot et al., NPJ Vaccines (2025) 🔹 Using JPT’s Custom Peptide Synthesis to produce ESR-1 mutation sequences commonly occurring in HR+ Breast Cancer and test for neo-antigens: 𝗘𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗿𝗼𝗹𝗲 𝗼𝗳 𝗘𝗦𝗥1 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗺𝗲𝘁𝗮𝘀𝘁𝗮𝘁𝗶𝗰 𝗵𝗼𝗿𝗺𝗼𝗻𝗲 𝗿𝗲𝗰𝗲𝗽𝘁𝗼𝗿-𝗽𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝗧 𝗰𝗲𝗹𝗹 𝗶𝗺𝗺𝘂𝗻𝗲 𝘀𝘂𝗿𝘃𝗲𝗶𝗹𝗹𝗮𝗻𝗰𝗲 𝗱𝗶𝘀𝗿𝘂𝗽𝘁𝗶𝗼𝗻 ✍ Morgane Lopez et al., Breast Cancer Research (2025) – PMID: 39920833 🔹 When looking at the possible oncogenicity of RAF and the role of evading regulatory factors such as the Cdc37/HSP90 chaperone machinery, SPOT synthesis was employed to create binding sites of BRAF in a binding affinity assay: 𝗢𝗻𝗰𝗼𝗴𝗲𝗻𝗶𝗰 𝗻𝗼𝗻-𝗩600 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝗲𝘃𝗮𝗱𝗲 𝘁𝗵𝗲 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗺𝗮𝗰𝗵𝗶𝗻𝗲𝗿𝘆 𝗼𝗳 𝗥𝗔𝗙 𝗶𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗖𝗱𝗰37/𝗛𝘀𝗽90 𝗰𝗵𝗮𝗽𝗲𝗿𝗼𝗻𝗲 𝗮𝗻𝗱 𝘁𝗵𝗲 14-3-3 𝘀𝗰𝗮𝗳𝗳𝗼𝗹𝗱 ✍ Wan et al., Theranostics (2025) – PMID: 39897565 🔹 When it comes to investigating new paracetamol derivatives, quantitative expression of inflammatory markers s in BV2 microglial cells was analyzed via LC-MS/MS with absolutely quantified peptides: 𝗔 𝗻𝗼𝘃𝗲𝗹 𝗽𝗮𝗿𝗮𝗰𝗲𝘁𝗮𝗺𝗼𝗹 𝗱𝗲𝗿𝗶𝘃𝗮𝘁𝗶𝘃𝗲 𝗮𝗹𝗹𝗲𝘃𝗶𝗮𝘁𝗲𝘀 𝗹𝗶𝗽𝗼𝗽𝗼𝗹𝘆𝘀𝗮𝗰𝗰𝗵𝗮𝗿𝗶𝗱𝗲-𝗶𝗻𝗱𝘂𝗰𝗲𝗱 𝗻𝗲𝘂𝗿𝗼𝗶𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 ✍ Adela Kralova et al., European Journal of Pharmacology (2025) – PMID: 39986592 🔎 𝗪𝗮𝗻𝘁 𝗺𝗼𝗿𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀? Follow us and stay tuned for next month’s roundup! #myjpt #jptpaper #peptiderange #pepmix #spikemix
-
Check out this interesting background on the Berlin-based Biotech Park Adlershof where JPT is based.
Tech-Oase im Wandel: So bleibt #Adlershof auf Zukunftskurs 🧭 Der Erfolg des Technologieparks Adlershof ist hausgemacht, über viele Jahre hat sich hier ein einzigartiges, fruchtbares und resilientes Ökosystem, das auf starke Netzwerke, Wissenstransfer und Kooperationen setzt, entwickelt. Wir sprechen in der Journal-Frühlingsausgabe mit Menschen aus dem Technologiepark, die die passenden Arbeitsumgebungen und Strukturen schaffen, um auf Erfolgskurs zu bleiben und weiterhin schlaue Köpfe aus aller Welt anzuziehen. 💼 Axel Gutzmer, Leiter Vermietung bei WISTA schwört hierfür auf physische Orte zur Vernetzung, ebenso wie Netzwerkmanager Daniel Rosón Eichelmann, setzt er auf Begegnung und Austausch und eine #Arbeitsumgebung, die inspiriert und Kreativität befördert. Zu finden in den #Arbeitswelten im New Work ST3AM, welche wir in dieser Ausgabe vorstellen. Wir sprechen unter anderem mit Gregor Wrobel (Geschäftsführer Gesellschaft zur Förderung angewandter Informatik (GFaI) e.V.), der digitale Projekte mittelständischer Unternehmen fördert und fest mit Adlershof verwurzelt ist. Mit Aurélien Claeyssen von JPT Peptide Technologies, dessen Firma seit 2004 erfolgreich am Standort wächst und Clean Ocean Coatings Geschäftsführerin Christina Linke, deren Unternehmen, mit sauberen Schiffsbeschichtungen, die Schifffahrt umweltfreundlicher machen will. ➡️ Wir wünschen eine anregende Lektüre 😊: https://lnkd.in/e7DSHtYS
-
-
📢 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀! 𝗝𝗣𝗧 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝗡𝗲𝘅𝘁𝗚𝗲𝗻 𝗕𝗶𝗼𝗺𝗲𝗱 𝗶𝗻 𝗟𝗼𝗻𝗱𝗼𝗻! Join us from March 12 to14, 2025, as we connect with innovators shaping the future of biomedicine, drug development, and peptide research. NextGen Biomed by Oxford Global is the perfect stage to discuss cutting-edge peptide solutions and how they drive advancements in vaccine development, immune monitoring, and personalized medicine. 📍 Visit us at 𝗕𝗼𝗼𝘁𝗵 #13 🤝 Meet our experts: Dr. Michael Drosch & Gregory P. R. Hansen, PhD, MS Let’s explore how JPT’s 𝗵𝗶𝗴𝗵-𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗽𝗲𝗽𝘁𝗶𝗱𝗲 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 can empower your research and accelerate discoveries. Whether you're looking for custom peptides, PepMix™ Peptide Pools, or immune monitoring solutions, we’re here to help! 💬 𝗪𝗵𝗼’𝘀 𝗮𝘁𝘁𝗲𝗻𝗱𝗶𝗻𝗴 𝗡𝗲𝘅𝘁𝗚𝗲𝗻 𝗕𝗶𝗼𝗺𝗲𝗱? Drop a comment or DM us! we’d love to meet you there! #NextGenBiomed #Biotech #DrugDiscovery #Immunotherapy
-
-
Meet Gregory P. R. Hansen, PhD, MS at the XIX Iberian Peptide Meeting in Santiago de Compostela, Spain #EPI2025 #PeptideScience #myjpt #peptide
Providing tailored peptide solution for your project - JPT Peptide Technologies is part of BioNTech SE
Getting ready for the XIX Iberian Peptide Meeting (EPI 2025) 🧪🔬—a premier event bringing together Portuguese and Spanish researchers in #peptide science! 📅 Dates: from today February 26 to the 28th, 2025 📍 Location: Hospedería San Martín Pinario, Santiago de Compostela, Spain You can find me at the JPT Peptide Technologies booth! Let’s talk peptides 😉 💬✨ 🔗 Learn more: epi2025.com #EPI2025 #PeptideScience #Innovation #Networking #Research #Biotechnology #myjpt #peptide
-
-
A Free ELISpot Webinar in Munich, you say? Join us! The ELISpot Resource Group (ERG) regularly organizes free ELISpot/FluoroSpot workshops worldwide to inform about the ELISpot technique, new developments, and control. The ERG consists of ELISpot enthusiasts from ZellNet Consulting, Mabtech, Merck Group, and yours truly, JPT Peptide Technologies. This time, the next ELISpot workshop will be hosted by BioNTech SE in Munich on April 2nd. We are excited to meet you. So, sign up & let’s connect! Please find the signup link in the comments 💬 👇 #myjpt #elispot #webinar Sylvia Janetzki
-